Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

HSP

Hospira (HSP)

De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:HSP
DataHoraFonteTítuloCódigoCompanhia
04/02/201416:50ZacksIs Perrigo (PRGO) Poised to Beat Earnings Estimates? - Analyst BlogNYSE:HSP
09/01/201417:14PR Newswire (US)Hospira to Host Conference Call for Fourth-Quarter 2013 Results and 2014 ProjectionsNYSE:HSP
17/12/201316:34PR Newswire (US)Hospira to Present at the J.P. Morgan 32nd Annual Healthcare Conference Jan. 15, 2014NYSE:HSP
26/11/201314:02PR Newswire (US)Hospira to Host 2013 Investor DayNYSE:HSP
15/11/201311:46Dow Jones NewsGlenview Capital Management 3Q 13F: Holdings As Of Sep 30NYSE:HSP
15/11/201311:46Dow Jones NewsGlenview Capital Management 3Q 13F: Largest SalesNYSE:HSP
06/11/201312:41Dow Jones NewsU.S. Hot Stocks Futures: Hot Stocks to WatchNYSE:HSP
06/11/201311:13Edgar (US Regulatory)Quarterly Report (10-q)NYSE:HSP
06/11/201311:03Edgar (US Regulatory)Current Report Filing (8-k)NYSE:HSP
06/11/201310:30PR Newswire (US)Hospira Reports Third-Quarter 2013 ResultsNYSE:HSP
31/10/201315:01PR Newswire (US)Hospira Shares Results From Two Open-label Extension Studies for Biosimilar Infliximab in Patients With Rheumatoid Arthritis ...NYSE:HSP
29/10/201316:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:HSP
23/10/201315:30PR Newswire (US)Hospira Unveils New Quality Laboratory and Investments at Rocky Mount, N.C., PlantNYSE:HSP
23/10/201312:02PR Newswire (US)Hospira Launches Q Core Sapphire Infusion System in the United StatesNYSE:HSP
22/10/201312:08PR Newswire (US)Biosimilars Need Same Names as Original Biologics, Hospira Says at World Health Organization (WHO) MeetingNYSE:HSP
11/10/201319:09ZacksCerner HIT Solutions Enter Brazil - Analyst BlogNYSE:HSP
07/10/201317:20PR Newswire (US)Hospira to Host Conference Call for Third-Quarter 2013 ResultsNYSE:HSP
10/09/201306:39PR Newswire (US)Hospira's Inflectra™ (infliximab) the first biosimilar monoclonal antibody to be approved in EuropeNYSE:HSP
13/08/201313:34PR Newswire (US)Hospira to Present at the Morgan Stanley Global Healthcare ConferenceNYSE:HSP
07/08/201318:21Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NYSE:HSP
07/08/201310:35Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NYSE:HSP
31/07/201309:20Edgar (US Regulatory)Definitive Materials Filed by Investment Companies. (497)NYSE:HSP
31/07/201308:46PR Newswire (US)Hospira Reports Second-Quarter 2013 ResultsNYSE:HSP
30/07/201318:04Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NYSE:HSP
12/07/201316:53Dow Jones NewsMedicines Co. Receives Unfavorable Claim Construction Ruling in Patent SuitNYSE:HSP
10/07/201313:00ZacksHospira Touches 52-week High - Analyst BlogNYSE:HSP
28/06/201315:05Dow Jones NewsEU Regulators Recommend Approval of Hospira's Remicade CopyNYSE:HSP
28/06/201313:53PR Newswire (US)Hospira to Host Conference Call for Second-Quarter 2013 ResultsNYSE:HSP
28/06/201308:54PR Newswire (US)Hospira's Inflectra™ (infliximab) the first biosimilar monoclonal antibody to receive positive opinion from EMA's CHMP for ...NYSE:HSP
03/06/201315:57PR Newswire (US)Hospira Data on European Biosimilar Epoetin, Retacrit, Affirm Treatment Response, Tolerability in Management of Anemia Second...NYSE:HSP
 Apresentando as notícias mais relevantes sobre:NYSE:HSP